Former Valeant executive and Philidor CEO charged with fraud
pharmafile | November 18, 2016 | News story | Medical Communications, Sales and Marketing | Philidor, Valeant, Valeant Pharmaceuticals, fraud
Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US attorney for the Southern District of New York, has accused Tanner and Davenport of conducting “multi-million dollar fraud and kickback scheme” against Valeant.
The full complaint suggests that Tanner and Davenport created Philidor through Tanner’s relationship to Valeant, as the dominant sales channel for Valeant. Tanner allegedly hid his interests to Philidor from his superiors. Eventually the scheme allowed Tanner and Davenport to accrue an individual fortune of $10 million and $40 million, respectively.
“Today, we charge corporate fraud at Valeant Pharmaceuticals. Gary Tanner, a former Valeant executive, and Andrew Davenport, the CEO of Philidor, allegedly concocted a fraudulent scheme to illegally use Philidor as a vehicle for personal profit and self-dealing,” U.S. Attorney Bharara said in a statement. “Their alleged kickback scheme illegally converted Valeant shareholder money into their own personal nest eggs. As alleged, while purporting to be arms-length business counterparts, the two men were, in fact, partners in crime”.
The news, though adding further damage after a difficult month, could be worse for Valeant. There has been, as yet, no implication in their former CEO and CFO in the investigation for fraud.
“Valeant Pharmaceuticals International today learned that a criminal complaint was filed in relation to Philidor. Gary Tanner and Andrew Davenport were charged in the matter. The company, former CEO, former CFO and current executives have not been charges at this time,” Valeant said in a statement on 17 November. “The counts issued today include allegations that the charged parties engaged in actions to defraud Valeant as a company. Valeant continues to cooperate with all relevant authorities in this matter”.
Ben Hargreaves
Related Content
CEO of PixarBio Corporation sentenced to prison for defrauding investors
Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in …
Teva settles $135 million dollar fraud case over Medicaid price inflation
Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently …
Digital system may prevent £300m prescription fraud losses for NHS by 2020
The British government are launching a new digitised system aimed at cracking down on prescription …
